# US 2026/0083883 A1 · Recombinant human type iii collagen for promoting angiogenesis, and preparation method and application method thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083883 A1
- Document ID: US20260083883A1
- Status: Published application
- Kind: A1
- Application number: 19/035,974
- Filed: 2025-01-24
- Published: 2026-03-26
- Earliest claimed: 2024-09-26
- Assignees: Northwest University
- Applicants: Northwest University
- Inventors: Weina Li; Yaqian Zhang; Daidi Fan; Xinyue Deng; Yanting Yuan; Qiyi Jiang; Ziyang Niu; Jingwen Zhai; Linmiao Song; Min Yang; Zhe Wan; Xinzheng Fu; Tingyuan Xiao
- Web page: https://patentgrep.com/patent/US20260083883A1

## CPC

- A61L 31/044: {Collagen}
- A61L 27/24: Collagen
- A61L 27/507: {for artificial blood vessels (apparatus for applying cells on a blood vessel prosthesis A61F2/062)}
- C07K 1/36: by a combination of two or more processes of different types
- C07K 14/78: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- C12N 1/165: Yeast isolates
- C12N 15/815: {for yeasts other than Saccharomyces}
- A61L 2430/34: for soft tissue reconstruction
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Recombinant human type III collagen for promoting angiogenesis, and a preparation method and an application method thereof are provided, which relate to the field of genetic engineering technologies. The amino acid of the recombinant human type III collagen is as shown in SEQ ID NO: 1. The method replaces nine different sites of a full-length natural type III collagen with a GFOGER sequence from type I collagen specifically binding to integrin sites, thereby enhancing promote angiogenic function without changing a total length of natural full-length amino acids. Meanwhile, the method replaces four natural integrin sites with lower adhesion rates, thus the recombinant type III collagen have higher adhesion, to further promote angiogenesis. Through this modification method, the angiogenesis rate will be increased by more than 37%, and the molecular weight of protein translated by the recombinant human type III collagen is moderate, making it easy to prepare.

## Claims

### Claim 1

Recombinant human type III collagen for promoting angiogenesis, wherein the amino acid sequence of the recombinant human type III collagen is as shown in SEQ ID NO: 1.

### Claim 2 (depends on 1)

A gene encoding the recombinant human type III collagen as claimed in claim 1, wherein the nucleotide sequence of the gene is as shown in SEQ ID NO: 2.

### Claim 3 (depends on 1)

An application method of the recombinant human type III collagen as claimed in claim 1, comprising:
preparing a cardiovascular stent material or an artificial blood vessel by using the recombinant human type III collagen.

### Claim 4 (depends on 1)

An application method of the recombinant human type III collagen as claimed in claim 1, comprising:
preparing a skin tissue repair material by using the recombinant human type III collagen.

### Claim 5 (depends on 1)

An application method of the recombinant human type III collagen as claimed in claim 1, comprising:
preparing a preparation for treating cardiovascular diseases by using the recombinant human type III collagen.

### Claim 6 (depends on 2)

An expression vector, comprising the gene as claimed in claim 2.

### Claim 7 (depends on 6)

A host cell, comprising the expression vector as claimed in claim 6.

### Claim 8 (depends on 7)

The host cell as claimed in claim 7, wherein the host cell is any one selected from the group consisting of Pichia pastoris, Saccharomyces cerevisiae, Escherichia coli, and Bacillus subtilis.

### Claim 9 (depends on 7)

A method for preparing the recombinant human type III collagen by using the host cell as claimed in claim 7, comprising:
cultivating the host cell in a culture medium, and inducing expression of the recombinant human type III collagen to obtain an induced product, and purifying the induced product to obtain the recombinant human type III collagen.

### Claim 10 (depends on 9)

The method as claimed in claim 9, wherein a method for the purifying is any one selected from the group consisting of a salting-out method, an ultrafiltration method, an affinity chromatography method and a gel filtration chromatography method.
